AAAAAA
Results:
1-11
|
Results: 11
Authors:
MASUDA N
MATSUI K
NEGORO S
TAKIFUJI N
TAKEDA K
YANA T
KOBAYASHI M
HIRASHIMA T
KUSUNOKI Y
USHIJIMA S
KAWASE I
TADA T
SAWAGUCHI H
FUKUOKA M
Citation: N. Masuda et al., COMBINATION OF IRINOTECAN AND ETOPOSIDE FOR TREATMENT OF REFRACTORY OR RELAPSED SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 16(10), 1998, pp. 3329-3334
Authors:
KOMIYA T
KUSUNOKI Y
KOBAYASKI M
HIRASHIMA T
YANA T
MASUDA N
MATSUI K
TAKADA M
NAKAGAWA K
KOTAKE Y
YASUMITSU T
KIKUI M
KAWASE I
Citation: T. Komiya et al., TRANSCUTANEOUS NEEDLE-BIOPSY OF THE LUNG, Acta radiologica, 38(5), 1997, pp. 821-825
Authors:
FUKUOKA M
MASUDA N
NEGORO S
MATSUI K
YANA T
KUDOH S
KUSUNOKI Y
TAKADA M
KAWAHARA M
OGAWARA N
KODAMA N
KUBOTA K
FURUSE K
Citation: M. Fukuoka et al., CODE CHEMOTHERAPY WITH AND WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR IN SMALL-CELL LUNG-CANCER, British Journal of Cancer, 75(2), 1997, pp. 306-309
Authors:
MATSUI K
MASUDA N
UCHIDA Y
FUKUOKA M
NEGORO S
YANA T
KUSUNOKI Y
KUDOH S
KAWASE I
KAWAHARA M
OGAWARA M
KODAMA N
KUBOTA K
FURUSE K
Citation: K. Matsui et al., DETERMINANTS OF MYELOSUPPRESSION IN THE TREATMENT OF NONSMALL CELL LUNG-CANCER WITH CISPLATIN-CONTAINING CHEMOTHERAPY, Japanese journal of cancer research, 87(7), 1996, pp. 781-786
Authors:
MATSUI K
FUKUOKA M
TAKADA M
KUSUNOKI Y
YANA T
TAMURA K
YOSHIDA T
IIDA K
HIRASHIMA T
TSUKADA H
USHIJIMA S
MIYAWAKI H
MASUDA N
Citation: K. Matsui et al., RANDOMIZED TRIAL FOR THE PREVENTION OF DELAYED EMESIS IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN, British Journal of Cancer, 73(2), 1996, pp. 217-221
Authors:
TAKADA M
KUSUNOKI Y
MASUDA N
MATUI K
YANA T
USHIJIMA S
IIDA K
TAMURA K
KOMIYA T
KAWASE I
KIKUI N
MORINO H
FUKUOKA M
Citation: M. Takada et al., PRO-GASTRIN-RELEASING PEPTIDE(31-98) AS A TUMOR-MARKER OF SMALL-CELL LUNG-CANCER - COMPARATIVE-EVALUATION WITH NEURON-SPECIFIC ENOLASE, British Journal of Cancer, 73(10), 1996, pp. 1227-1232
Authors:
KUDOH S
FUKUOKA M
MASUDA N
YOSHIKAWA A
KUSUNOKI Y
MATSUI K
NEGORO S
TAKIFUJI N
NAKAGAWA K
HIRASHIMA T
YANA T
TAKADA M
Citation: S. Kudoh et al., RELATIONSHIP BETWEEN THE PHARMACOKINETICS OF IRINOTECAN AND DIARRHEA DURING COMBINATION CHEMOTHERAPY WITH CISPLATIN, Japanese journal of cancer research, 86(4), 1995, pp. 406-413
Authors:
NITTA T
FUKUOKA F
MASUDA N
KUSUNOKI Y
MATSUI K
KUDOH S
HIRASHIMA T
YANA T
ITOH K
TAKADA M
Citation: T. Nitta et al., SIGNIFICANCE OF SERUM NEURON-SPECIFIC ENOLASE AS A PREDICTOR OF RELAPSE OF SMALL-CELL LUNG-CANCER, Japanese Journal of Clinical Oncology, 25(5), 1995, pp. 179-183
Authors:
TAKADA M
MASUDA N
MATSUURA E
KUSUNOKI Y
MATUI K
NAKAGAWA K
YANA T
TUYUGUCHI I
OOHATA I
FUKUOKA M
Citation: M. Takada et al., MEASUREMENT OF CYTOKERATIN 19 FRAGMENTS AS A MARKER OF LUNG-CANCER BYCYFRA-21-1 ENZYME-IMMUNOASSAY, British Journal of Cancer, 71(1), 1995, pp. 160-165
Authors:
MASUDA N
FUKUOKA M
KUDOH S
MATSUI K
KUSUNOKI Y
TAKADA M
NAKAGAWA K
HIRASHIMA T
TSUKADA H
YANA T
YOSHIKAWA A
KUBO A
MATSUURA E
NITTA T
TAKIFUJI N
TERAKAWA K
NEGORO S
Citation: N. Masuda et al., PHASE-I AND PHARMACOLOGICAL STUDY OF IRINOTECAN AND ETOPOSIDE WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT FOR ADVANCED LUNG-CANCER, Journal of clinical oncology, 12(9), 1994, pp. 1833-1841
Authors:
MASUDA N
FUKUOKA M
KUDOH S
KUSUNOKI Y
MATSUI K
NAKAGAWA K
HIRASHIMA T
TAMANOI M
NITTA T
YANA T
NEGORO S
TAKIFUJI N
TAKADA M
Citation: N. Masuda et al., PHASE-I STUDY OF IRINOTECAN AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT FOR ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 12(1), 1994, pp. 90-96
Risultati:
1-11
|